QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SRRK

QT54Scholar Rock Holding Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
47.33
+0.38+0.81%
OverviewShort InterestFilings
SRRKQT54Scholar Rock Holding Corporation·NASDAQ
OverviewShort InterestFilings
47.33+0.81%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-3.08
Insider Own47.87%
Shs Outstand119.83M
Perf Week5.91%
Market Cap5.63BForward P/E-EPS next Y-2.49Insider Trans-0.05%Shs Float-Perf Month-0.48%
Enterprise Value5.40BPEG0.54EPS next Q-0.84Inst Own-Short Float-Perf Quarter4.02%
Income-384813243.00P/S0.00EPS this Y-3.61%Inst Trans-Short Ratio-Perf Half Y6.79%
Sales-P/B21.65EPS next Y21.94%ROA-76.36%Short Interest-Perf YTD7.45%
Book/sh2.30P/C-EPS next 5Y-ROE-163.52%52W High52.19 -9.31%Perf Year51.94%
Cash/sh4.01P/FCF-EPS past 3/5Y-ROIC-85.03%52W Low27.07 74.84%Perf 3Y-
Dividend Est.-EV/EBITDA-13.51Sales past 3/5Y-Gross Margin0.00%Volatility3.22% 3.08%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-45.34%Oper. Margin0.00%ATR (14)2.14Perf 10Y-
Dividend Ex-Date-Quick Ratio8.64Sales Y/Y TTM-Profit Margin0.00%RSI (14)53.09Recom2.00
Dividend Gr. 3/5Y-Current Ratio8.64EPS Q/Q-23.88%SMA201.61%Beta1.22Target Price59.17
Payout0.00%Debt/Eq0.75Sales Q/Q-SMA50-0.39%Rel Volume2.34Prev Close46.95
Employees128LT Debt/Eq0.42EarningsAug 05SMA20012.37%Avg Volume1.31MPrice47.33
IPO DateMay 25, 2018Option/ShortYes / YesEPS/Sales Surpr.-1.22% -Net Debt/EBITDA0.56Volume3,058,253Change0.81%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedH.C. Wainwright$58 → $65
May-08-26ReiteratedBarclaysOverweight$53 → $55
Apr-20-26InitiatedCanaccordBuy$62
Mar-04-26ReiteratedPiper SandlerOverweight$51 → $58
Mar-03-26ReiteratedTruist Financial$55
Jan-26-26ReiteratedH.C. Wainwright$44 → $58
Jan-07-26ReiteratedUBS$60
Dec-17-25ReiteratedBarclaysOverweight$44 → $52
Nov-14-25ReiteratedBMO CapitalOutperform$45 → $50
Sep-24-25ReiteratedPiper SandlerOverweight$42 → $51
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4700
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A11502
Gross Profit-680-2
Selling, General and Administrative Excl. Other4117668
Research and Development115208183
Other Operating Expense-1151-1
Operating Income-109-385-252
Interest Expense177
Unusual Expense
———
Non-Operating Income (Expense)1-14-13
Net Income Before Taxes-113-378-246
Income Taxes
000
Consolidated Net Income-113-378-246
Net Income From Continuing Operations-113-378-246
Net Income-113-378-246
EPS (Recurring)-3.12-3.29-2.47
EPS (Basic, Before Extraordinaries)-3.12-3.29-2.47
EPS (Diluted)-3.08-3.29-2.47
EBITDA-108-369-238
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
37.26——
Gross Margin-144.68——
Operating Margin-231.91——
Net Margin-240.43——
Shares Outstanding37115100
Market Capitalization1,7515,066—
Operating Lease Expense
———
Insider Trading Volume
$58.13$52.48$46.83$41.17$35.52● Close Price0.00M5.00M9.99M14.99M19.99MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Burow KristinaDirectorApr 23 '26Option Exercise9.13179,6001,640,648110,871Apr 24 12:00 AM
Woods KeithChief Operating OfficerApr 16 '26Sale49.5710,220506,651620,055Apr 20 12:00 AM
Vaishnaw AkshayPresident of R&DApr 16 '26Sale49.5712,246607,089630,542Apr 20 12:00 AM
Sinha VikasChief Financial OfficerApr 16 '26Sale49.5710,410516,071619,856Apr 20 12:00 AM
Hallal DavidChief Executive OfficerApr 16 '26Sale49.5730,6151,517,7231,639,034Apr 20 12:00 AM
Qatanani MoCHIEF SCIENTIFIC OFFICERFeb 23 '26Sale47.078,484399,35198,445Feb 25 12:00 AM
Marantz Jing L.CHIEF MEDICAL OFFICERFeb 17 '26Sale46.534,157193,418126,012Feb 19 12:00 AM
Ho JunlinGENERAL COUNSELFeb 17 '26Sale46.539,580445,740241,545Feb 19 12:00 AM
Parlavecchio CarynCHROFeb 17 '26Sale46.539,035420,382169,087Feb 19 12:00 AM
Qatanani MoCHIEF SCIENTIFIC OFFICERFeb 17 '26Sale46.537,989371,714106,929Feb 19 12:00 AM
Invus Global Management, LLC10% OwnerDec 11 '25Option Exercise7.353,150,01623,152,61810,825,013Feb 06 12:00 AM
Qatanani MoCHIEF SCIENTIFIC OFFICERJan 22 '26Sale46.7114,898695,93885,660Jan 23 12:00 AM
Qatanani MoCHIEF SCIENTIFIC OFFICERJan 16 '26Sale44.488,406373,880100,558Jan 21 12:00 AM
Parlavecchio CarynCHROJan 16 '26Sale44.486,600293,553148,864Jan 21 12:00 AM
Marantz Jing L.CHIEF MEDICAL OFFICERJan 16 '26Sale44.485,798257,88295,687Jan 21 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR